Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Reproductive Sciences
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1933719108324893v1
16/2/140    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Taylor, R. N.
Right arrow Articles by Sidell, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R. N.
Right arrow Articles by Yu, J.
Right arrow Articles by Torres, P. B.
Right arrow Articles by Schickedanz, A. C.
Right arrow Articles by Park, J. K.
Right arrow Articles by Mueller, M. D.
Right arrow Articles by Sidell, N.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Endometriosis
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis

Robert N. Taylor1*, Jie Yu1, Paulo B. Torres1, Aimee C. Schickedanz1, John K. Park1, Michael D. Mueller2, and Neil Sidell1

1 Emory University School of Medicine
2 University of Bern

* To whom correspondence should be addressed. E-mail: robert.n.taylor{at}emory.edu.


  Abstract
Like tumor metastases, endometriotic implants require neovascularization to proliferate and invade into ectopic sites within the host. Endometrial tissue, with its robust stem cell populations and remarkable regenerative capabilities, is a rich source of proangiogenic factors. Among the most potent and extensively studied of these proteins, vascular endothelial growth factor has emerged as a critical vasculogenic regulator in endometriosis. Accordingly, angiogenesis of the nascent endometriotic lesion has become an attractive target for novel medical therapeutics and strategies to inhibit vascular endothelial growth factor action. Vascular endothelial growth factor gene regulation in endometrial and endometriosis cells by nuclear receptors, other transcription factors, and also by infiltrating immune cells is emphasized. New data showing that oxidative and endoplasmic reticulum stress increase vascular endothelial growth factor expression are provided. Finally, we review the clinical implications of angiogenesis in this condition and propose potential antiangiogenic therapies that may become useful in the control or eradication of endometriotic lesions.

First published on November 11, 2008, doi:10.1177/1933719108324893

Reproductive Sciences 2009;16:140.

A more recent version of this article appeared on February 1, 2009

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
F. Shen, X. Liu, J.-G. Geng, and S.-W. Guo
Increased Immunoreactivity to SLIT/ROBO1 in Ovarian Endometriomas: A Likely Constituent Biomarker for Recurrence
Am. J. Pathol., August 1, 2009; 175(2): 479 - 488.
[Abstract] [Full Text] [PDF]